Cellnovo is a London, UK based startup working on an interesting mobile diabetes management system, that is still mostly in stealth mode. The company hopes that its technology will make routine diabetics’ tasks and decisions more mobile, intuitive, and socially friendly, by integrating its insulin pump, as well as the touch-screen mobile-connected device, into a social network-like environment.
The investors are also impressed with the technology, as the company has just closed a Series B £30 million ($48.4 million) financing round.
A recent article in IN VIVO: The Business and Medicine Report, describes Cellnovo pump technology as the most accurate to come to the market in years.
To learn more about Cellnovo, here’s a link to the company website…
More: Diabetes management system could be ‘iTunes of diabetes care’ …